Treatment of myocardial interstitial fibrosis in pathological myocardial hypertrophy

被引:5
|
作者
Zhu, Fuyu [1 ]
Li, Peng [2 ]
Sheng, Yanhui [1 ,3 ]
机构
[1] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou Municipal Hosp, Gusu Sch,Dept Cardiol, Suzhou, Peoples R China
[2] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Peoples R China
[3] Jiangsu Prov Hosp, Dept Cardiol, Nanjing, Peoples R China
关键词
pathological myocardial hypertrophy; myocardial interstitial fibrosis; myofibroblasts; anti-fibrosis; biomarkers; LEFT-VENTRICULAR HYPERTROPHY; SEVERE AORTIC-STENOSIS; MYOSIN HEAVY-CHAIN; X RECEPTOR AGONIST; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; HEART-FAILURE; ENDOPLASMIC-RETICULUM; DILATED CARDIOMYOPATHY; HYPERTENSIVE PATIENTS;
D O I
10.3389/fphar.2022.1004181
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pathological myocardial hypertrophy can be caused by a variety of diseases, mainly accompanied by myocardial interstitial fibrosis (MIF), which is a diffuse and patchy process, appearing as a combination of interstitial micro-scars and perivascular collagen fiber deposition. Different stimuli may trigger MIF without cell death by activating a variety of fibrotic signaling pathways in mesenchymal cells. This manuscript summarizes the current knowledge about the mechanism and harmful outcomes of MIF in pathological myocardial hypertrophy, discusses the circulating and imaging biomarkers that can be used to identify this lesion, and reviews the currently available and potential future treatments that allow the individualized management of patients with pathological myocardial hypertrophy.
引用
收藏
页数:12
相关论文
共 50 条
  • [11] Angiotensin Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis and Diastolic Dysfunction
    Oudit, Gavin Y.
    Zhong, Jiuchang
    Basu, Ratnadeep
    Guo, Danny
    Penninger, Josef M.
    Kassiri, Zamaneh
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (08) : S16 - S16
  • [12] MYOCARDIAL INTERSTITIAL FIBROSIS IN UREMIA - IS IT RELEVANT
    AMANN, K
    MALL, G
    RITZ, E
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (02) : 127 - 128
  • [13] Evolution of ventricular hypertrophy and myocardial mechanics in physiological and pathological hypertrophy
    Yalcin, Fatih
    Kucukler, Nagehan
    Cingolani, Oscar
    Mbiyangandu, Blaid
    Sorensen, Lars
    Pinherio, Aurelio
    Abraham, M. Roselle
    Abraham, Theodore P.
    JOURNAL OF APPLIED PHYSIOLOGY, 2019, 126 (02) : 354 - 362
  • [14] PATHOLOGICAL-STUDY OF REGIONAL INTERSTITIAL MYOCARDIAL FIBROSIS IN PATIENTS WITH DILATED CARDIOMYOPATHY (DCM)
    MAEHASHI, N
    YOKOTA, Y
    TAKARADA, A
    SEO, T
    KUBO, M
    MASUDA, J
    NAKANISHI, O
    USUKI, S
    FUKUZAKI, H
    SUGUYAMA, T
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1986, 50 (08): : 711 - 711
  • [15] Surgical treatment of HOCM in patients with extreme hypertrophy and septal myocardial fibrosis
    Borisov, K. V.
    EUROPEAN HEART JOURNAL, 2013, 34 : 502 - 503
  • [16] IDIOPATHIC CARDIAC HYPERTROPHY WITH SUBENDOCARDIAL AND MYOCARDIAL FIBROSIS
    MYERS, G
    HANELIN, J
    MALLORY, TB
    NEW ENGLAND JOURNAL OF MEDICINE, 1951, 245 (12): : 467 - 471
  • [17] Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction
    Zhong, JiuChang
    Basu, Ratnadeep
    Guo, Danny
    Chow, Fung L.
    Byrns, Simon
    Schuster, Manfred
    Loibner, Hans
    Wang, Xiu-hua
    Penninger, Josef M.
    Kassiri, Zamaneh
    Oudit, Gavin Y.
    CIRCULATION, 2010, 122 (07) : 717 - U40
  • [18] PREVENTION OF PATHOLOGICAL HYPERTROPHY, MYOCARDIAL FIBROSIS AND CARDIAC DYSFUNCTION BY ANGIOTENSIN-CONVERTING ENZYME 2
    Zhong, J.
    Basu, R.
    Guo, D.
    Chow, F. L.
    Bryns, S.
    Shuster, M.
    Loibner, H.
    Wang, X.
    Penninger, J. M.
    Kassiri, Z.
    Oudit, G. Y.
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 72D - 72D
  • [19] EFFECT OF CAPTOPRIL ON THE PREVENTION AND REGRESSION OF MYOCARDIAL-CELL HYPERTROPHY AND INTERSTITIAL FIBROSIS IN PRESSURE OVERLOAD CARDIAC-HYPERTROPHY
    ROSSI, MA
    PERES, LC
    AMERICAN HEART JOURNAL, 1992, 124 (03) : 700 - 709
  • [20] Atherosclerosis and pathological findings in the myocardium: The association between coronary raised lesions and myocardial interstitial fibrosis
    Tupiniquim Bina, M.
    Allen Ciuffo, L.
    Batista da Silva Filho, V.
    Arnon Bremer Soares, P.
    Abensur Athanazio, D.
    Amorim dos Santos Felix, R.
    VIRCHOWS ARCHIV, 2014, 465 : S131 - S131